Patient characteristics
Study no. | Age | Sex | Race | Treatment | cTNM | pTNM | Site | Grade | RFS (mo) | Status | Death cause |
---|---|---|---|---|---|---|---|---|---|---|---|
MD8E3 | 74 | M | N/A | N/A | T3N2bM0 | T3N2bM0 | OC | Poor | N/A | N/A | DOD |
VA291 | 47 | M | W | s→xrt/chemo | T3N2bM0 | T3N2bM0 | OP | Moderate | 10 | NED | DOC |
VA424 | 56 | M | W | s→xrt | T4N2bM0 | T4N2bM0 | OP | Moderate | 72 | NED | Alive |
VU119 | 44 | M | W | s→xrt | T1N2bM0 | T1N2bM0 | OP | Moderate | 105 | NED | Alive |
VU150 | 60 | M | B | s→xrt | T2N2bM0 | T2N2bM0 | OP | Moderate | 81 | NED | DOC |
VU265 | 58 | M | W | s→xrt | T2N2bM0 | T2N2bM0 | OC | Moderate | 86 | NED | Alive |
VU283 | 47 | M | W | s→xrt/chemo | T2N2aM0 | T2N2aM0 | OP | Moderate | 58 | NED | Alive |
VU284 | 63 | M | W | s→xrt/chemo | T4N1M0 | T4N1M0 | OP | Moderate | 12 | NED | DOC |
VU285 | 60 | M | W | s→xrt | T1N2bM0 | T1N2bM0 | OC | Poor | 83 | NED | Alive |
VU300148 | 50 | M | W | s only | T3N0M0 | T3N0M0 | L | Moderate | 28 | NED | Alive |
VU300249 | 77 | M | H | i→ccr→s | T3N3M0 | N/A | OP | Moderate | 25 | NED | Alive |
VU36 | 41 | F | W | s→xrt/chemo | T1N2cM0 | T1N2cM0 | L | Well | 38 | NED | DOC |
VU53 | 55 | M | W | s→xrt | T3N0M0 | T3N0M0 | L | Moderate | 77 | NED | DOC |
VU300637 | 69 | M | W | s→xrt/chemo | T2N1M0 | T1N1M0 | OC | Well | 10 | NED | Alive |
VU30111 | 61 | M | W | s→xrt | T1N1M0 | T4N0M0 | OC | Moderate | 5 | NED | Alive |
VA248 | 52 | M | B | s→xrt | T2N1M0 | T2N1M0 | OP | Moderate | 4 | REC | DOD |
VA418 | 54 | M | W | s→xrt | T2N2a | T4N2bM0 | OP | Moderate | 70 | REC | Alive |
VA435 | 57 | M | W | s→xrt/chemo | T3N2cM0 | T3N2cM0 | OC | Moderate | 22 | REC | DOD |
VU13703 | 57 | M | W | s→xrt | T3N0M0 | T2N2bM0 | OC | Well | 21 | REC | Alive |
VU640 | 53 | M | W | s→xrt/chemo | T3N1M0 | T2N2bM0 | OC | Moderate | 9 | REC | Alive |
VU132 | 58 | M | W | s→xrt/chemo | T4N2bM0 | T2N2bM0 | OC | Moderate | 8 | REC | DOD |
VU291 | 78 | M | W | s only | T2N0M0 | T2N0M0 | OP | Moderate | 6 | REC | DOC |
VU300663 | 47 | F | W | s only | T2N0M0 | T2N0M0 | OC | Moderate | 14 | REC | Alive |
VU6018 | 74 | M | W | s only | T2N0M0 | T2N0M0 | OC | Moderate | 25 | REC | Alive |
VU17956 | 41 | M | O | s→xrt | T2N0M0 | T2N1M0 | OC | Moderate | 6 | REC | Alive |
MD147E5 | 81 | M | W | s→xrt | T4N2aM0 | T4N2aM0 | L | Moderate | 13 | REC | DOD |
MD337H8 | 56 | M | W | s→xrt | T4N2cM0 | T4N0M0 | OC | Moderate | 18 | REC | DOD |
VU232 | 80 | M | W | s→xrt/chemo | T4N1M0 | T4N2cM0 | L | Moderate | 27 | REC | DOD |
VU260 | 55 | M | W | s→xrt/chemo | T2N3M0 | T2N3M0 | OP | Moderate | 16 | REC | DOC |
Abbreviations: cTNM, clinical TNM; pTNM, pathologic TNM; s, surgery; xrt, radiation therapy; xrt/chemo, concurrent chemoradiation therapy; i→ccr→s, induction chemotherapy followed by concurrent chemoradiation therapy and salvage surgery; OC, oral cavity; OP, oropharynx; L, larynx; NED, no evidence of disease; REC, recurrence; DOC, died of other cause; DOD, died of disease.